Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Vaxcell-Bio Therapeutics (323990) Stock Price & Analysis

323990 Stock Chart & Stats

₩3,725.00-₩65.00(-1.72%)
At close: 3:30 PM GMT+9
KRW 3,500KRW 4,000KRW 4,500KRW 5,0003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
KRW 3,665.00 - KRW 3,840.00
52-Week Range
KRW 3,350.00 - KRW 11,520.00
Previous Close
KRW 3,790.00
Volume
N/A
Average Volume (3M)
68.25K
Market Cap
KRW 86.32B
Enterprise Value
KRW 105.13B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
―
Beta
0.17
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

323990 FAQ

What was Vaxcell-Bio Therapeutics’s price range in the past 12 months?
Vaxcell-Bio Therapeutics lowest stock price was ₩3350.00 and its highest was ₩11520.00 in the past 12 months.
What is Vaxcell-Bio Therapeutics’s market cap?
Vaxcell-Bio Therapeutics’s market cap is ₩86.32B.
When is Vaxcell-Bio Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vaxcell-Bio Therapeutics’s earnings last quarter?
Vaxcell-Bio Therapeutics released its earnings results on Aug 14, 2026. The company reported -₩174.605 earnings per share for the quarter.
Is Vaxcell-Bio Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Vaxcell-Bio Therapeutics pay dividends?
Vaxcell-Bio Therapeutics does not currently pay dividends.
What is Vaxcell-Bio Therapeutics’s EPS estimate?
Vaxcell-Bio Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaxcell-Bio Therapeutics have?
Vaxcell-Bio Therapeutics has 23,257,345 shares outstanding.
What happened to Vaxcell-Bio Therapeutics’s price movement after its last earnings report?
Vaxcell-Bio Therapeutics reported an EPS of -₩174.605 in its last earnings report. Following the earnings report the stock price went down -1.839%.
Which hedge fund is a major shareholder of Vaxcell-Bio Therapeutics?
Currently, no hedge funds are holding shares in KR:323990
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology